How to Get Tadalafil (Generic) in South Dakota

At a glance
- Generic tadalafil doses / 2.5 mg, 5 mg, 10 mg, and 20 mg oral tablets
- Telehealth prescribing in SD / Yes, fully permitted under state law
- 503A compounding pharmacy access / Yes, licensed pharmacies may compound and ship tadalafil
- SD Medicaid coverage / Not covered for erectile dysfunction or BPH
- Who can prescribe / MDs, DOs, NPs (independent practice state), and PAs
- Average cash price for 30-day supply / $8 to $30 for generic tadalafil 5 mg daily
- FDA-approved indications / Erectile dysfunction, benign prostatic hyperplasia, pulmonary arterial hypertension
- Patent expiration / Original Cialis patent expired November 2017
- Time to effect (on-demand dosing) / 30 to 45 minutes, with a 36-hour activity window
South Dakota Telehealth Rules for Tadalafil Prescribing
South Dakota allows licensed prescribers to evaluate, diagnose, and prescribe medications via telehealth without requiring an initial in-person visit for most conditions, including erectile dysfunction. The state enacted telehealth parity legislation (SDCL 36-4-47) that recognizes synchronous audio-video consultations as a valid basis for establishing a prescriber-patient relationship. This means a man in Rapid City or Sioux Falls can complete a medical intake, answer screening questions, and receive a tadalafil prescription during a single video visit.
The South Dakota Board of Medical and Osteopathic Examiners requires that telehealth prescribers hold an active South Dakota medical license or practice under a valid interstate compact. Platforms operating nationally must verify their clinicians carry SD-specific credentials before writing prescriptions delivered to SD addresses. A telehealth visit for ED typically lasts 10 to 15 minutes, covers cardiovascular risk screening, medication history, and nitrate contraindication checks, and results in either a prescription sent to a pharmacy of the patient's choice or a recommendation for in-person follow-up if red flags appear 1.
Tadalafil is classified as a prescription-only, non-controlled medication. No DEA scheduling restrictions apply, so telehealth platforms can prescribe and ship it without the added verification steps that controlled substances require in South Dakota.
Generic Tadalafil: Doses, Indications, and How It Works
Tadalafil is a phosphodiesterase type 5 (PDE5) inhibitor originally approved by the FDA in November 2003 under the brand name Cialis. The compound inhibits PDE5 in the smooth muscle of the corpus cavernosum and prostatic tissue, increasing cyclic guanosine monophosphate (cGMP) levels and producing vasodilation 2. That mechanism supports two FDA-approved uses relevant to South Dakota patients: erectile dysfunction and benign prostatic hyperplasia (BPH), with a combined ED/BPH indication for men who have both conditions.
The dosing split matters clinically. Daily low-dose tadalafil (2.5 mg or 5 mg taken once per day regardless of sexual activity) maintains a steady plasma concentration that produces continuous smooth-muscle relaxation. On-demand dosing (10 mg or 20 mg taken 30 to 45 minutes before anticipated activity) produces higher peak concentrations but requires timing. In the key trial by Brock et al. (2002, N=348), tadalafil 20 mg improved the International Index of Erectile Function (IIEF) erectile function domain score by 7.9 points versus 1.2 for placebo (P<0.001) 1. The 36-hour half-life of tadalafil, compared to 4 to 5 hours for sildenafil, gives it the widest activity window among PDE5 inhibitors.
Generic tadalafil became available in the United States after the Cialis patent expired in November 2017. Multiple manufacturers now produce the drug, which has driven 30-tablet prices for the 5 mg daily dose below $15 at many pharmacies.
Who Can Prescribe Tadalafil in South Dakota
South Dakota is an independent-practice state for nurse practitioners. That distinction expands prescribing access in rural counties where physician density is low. Three categories of prescribers can write a tadalafil prescription in SD:
Physicians (MD/DO). Any physician with an active SD license and an unrestricted prescriptive authority registration can prescribe tadalafil. No specialty restriction applies; family medicine, internal medicine, and urology physicians all prescribe PDE5 inhibitors routinely.
Nurse Practitioners (NP). Under SDCL 36-9A, NPs who have completed at least 1 to 080 hours of supervised practice may apply for independent prescriptive authority. Once granted, they prescribe without a collaborative agreement. This is particularly relevant in western South Dakota, where NPs often serve as primary care providers in communities without a resident physician 3.
Physician Assistants (PA). PAs prescribe under a supervisory agreement with a licensed physician. The supervising physician does not need to be physically present during the encounter, and the agreement can accommodate telehealth-based supervision.
All three prescriber types can conduct the visit via telehealth, provided they hold proper SD licensure and follow the state's telehealth practice standards.
What Labs and Screening Are Required Before a Prescription
No state-mandated laboratory panel exists for tadalafil prescribing in South Dakota. The clinical standard of care, guided by the American Urological Association (AUA) 2018 guidelines for ED management, calls for a focused history, cardiovascular risk stratification, and a basic metabolic assessment 4.
A typical pre-prescribing workup includes:
- Cardiovascular screening. Blood pressure measurement and review of cardiac history. The AUA and the Princeton III Consensus recommend stratifying patients into low, intermediate, or high cardiovascular risk before initiating PDE5 inhibitor therapy 5. Low-risk patients can start tadalafil without further cardiac workup.
- Medication review. Absolute contraindication exists for concurrent use of organic nitrates (nitroglycerin, isosorbide mononitrate, isosorbide dinitrate) and tadalafil. Alpha-blocker co-administration requires dose titration caution due to additive hypotensive effects 2.
- Optional labs. Fasting glucose or HbA1c, lipid panel, total testosterone, and thyroid-stimulating hormone (TSH) can help identify underlying metabolic or endocrine causes of ED. These are recommended but not required before prescribing. A 2005 meta-analysis of 12 randomized trials found that metabolic comorbidities reduced PDE5 inhibitor response rates by approximately 15 to 20 percentage points compared to otherwise healthy men 3.
Telehealth platforms typically collect self-reported blood pressure, medication lists, and health history through a structured intake form. If a patient reports unstable angina, recent stroke (within 6 months), or uncontrolled hypertension, most platforms will decline to prescribe and refer for in-person evaluation.
Pharmacy Access and 503A Compounding in South Dakota
South Dakota residents have three pharmacy pathways for filling a generic tadalafil prescription.
Retail chain pharmacies. Walgreens, Lewis Drug, and other chains across Sioux Falls, Rapid City, Aberdeen, and Brookings stock FDA-approved generic tadalafil in standard doses (2.5, 5, 10 to 20 mg). GoodRx-reported cash prices in SD range from $8 to $25 for 30 tablets of tadalafil 5 mg, depending on the pharmacy and manufacturer.
Mail-order pharmacies. Many telehealth platforms partner with licensed mail-order pharmacies that ship directly to SD addresses. Delivery timelines typically run 3 to 7 business days from prescription approval. Some platforms offer monthly subscription models that include the consultation fee and medication in a single price.
503A compounding pharmacies. The South Dakota Board of Pharmacy licenses 503A compounding pharmacies to prepare patient-specific prescriptions. These pharmacies may compound tadalafil in non-standard doses (for example, 3 mg or 7.5 mg tablets, sublingual troches, or combination formulations with other active ingredients) when a prescriber determines that a commercially available dose is not appropriate. 503A pharmacies in SD can ship compounded tadalafil within the state; interstate shipping follows individual state reciprocity rules and FDA guidance under Section 503A of the Federal Food, Drug, and Cosmetic Act 6.
A critical distinction: FDA-approved generic tadalafil has undergone bioequivalence testing and is manufactured under current Good Manufacturing Practice (cGMP) standards. Compounded tadalafil has not. The FDA's 2023 warning letter campaign emphasized that compounded versions of commercially available drugs should only be dispensed when a specific clinical need (allergy to an inactive ingredient, need for a non-standard dose form) is documented 6.
Insurance Coverage and Cash-Pay Economics in South Dakota
South Dakota Medicaid does not cover tadalafil for erectile dysfunction or BPH. This aligns with the majority of state Medicaid programs, which have excluded ED medications since the Deficit Reduction Act of 2005 restricted Medicaid reimbursement for drugs used to treat sexual dysfunction 7.
Commercial insurance coverage varies. Employer-sponsored plans and marketplace plans sold through Healthcare.gov in SD may cover generic tadalafil, but many apply prior authorization requirements or quantity limits. Common PA criteria include:
- Documented diagnosis of ED or BPH (ICD-10 codes N52.x or N40.x)
- Trial or contraindication for at least one other PDE5 inhibitor (often sildenafil)
- Quantity limits of 6 to 12 tablets per month for on-demand dosing, or 30 tablets per month for daily dosing
- Prescriber attestation that the patient is not concurrently taking nitrates
For patients paying cash, generic tadalafil is one of the most affordable prescription medications in the PDE5 class. A 90-day supply of tadalafil 5 mg daily can cost as little as $20 to $45 through discount programs. This represents a price decline exceeding 95% from the branded Cialis list price, which reached approximately $470 per month at patent expiration in 2017 8.
Tadalafil for BPH: The Overlapping Indication
South Dakota men over 50 should know that tadalafil 5 mg daily is the only PDE5 inhibitor with an FDA-approved indication for benign prostatic hyperplasia, specifically lower urinary tract symptoms (LUTS) associated with BPH. This distinction matters for insurance purposes: some plans that exclude ED coverage will cover tadalafil when prescribed for BPH with the N40.1 diagnosis code.
The key BPH trial data came from four 12-week randomized controlled trials pooling over 1,500 men with LUTS-BPH. Tadalafil 5 mg daily improved the International Prostate Symptom Score (IPSS) by 4.8 to 5.6 points from baseline versus 2.3 to 3.6 for placebo, with separation from placebo visible by week 1 9. The effect size is comparable to tamsulosin 0.4 mg, the most widely prescribed alpha-blocker for BPH, and the two drugs can be combined in refractory cases.
For men who have both ED and BPH, tadalafil 5 mg daily treats both conditions with a single tablet. That dual coverage can simplify medication regimens and reduce overall drug costs compared to taking separate medications for each condition.
Transferring a Prescription to a South Dakota Pharmacy
Prescription transfers follow standard Board of Pharmacy rules in SD. A patient who holds a valid tadalafil prescription from another state can request a transfer to any licensed SD pharmacy. The receiving pharmacy contacts the originating pharmacy, verifies the prescription details, and logs the transfer. Because tadalafil is not a controlled substance, no additional restrictions apply beyond the standard transfer protocol.
Patients moving to South Dakota from another state should note that prescription validity periods vary. South Dakota allows dispensing on a valid prescription for up to one year from the date written, consistent with most state pharmacy practice acts. If the original prescription is older than 12 months, a new evaluation (in-person or via telehealth) will be required.
Telehealth platforms that operate in both the origin and destination state can often reassign the prescription to an SD-licensed pharmacy within their network without a formal transfer, since the prescriber already holds multi-state licensure.
Safety, Side Effects, and When to Seek In-Person Care
Tadalafil's safety profile is well-characterized across more than two decades of clinical use. The most common adverse effects, reported in 2% or more of patients in clinical trials, include headache (11%), dyspepsia (7%), back pain (6%), nasal congestion (3%), myalgia (4%), and flushing (3%) 2. Back pain and myalgia are more frequently associated with tadalafil than with sildenafil or vardenafil, likely related to PDE11 cross-reactivity in skeletal muscle.
Rare but serious adverse events include:
- Priapism. Erection lasting more than 4 hours. Incidence is extremely low (<0.1%), but it constitutes a urological emergency requiring immediate treatment 10.
- Non-arteritic anterior ischemic optic neuropathy (NAION). Post-marketing reports exist but a causal relationship has not been established. The FDA label carries a warning, and patients with a history of NAION in one eye should discuss risks before starting any PDE5 inhibitor 2.
- Sudden sensorineural hearing loss. Case reports exist across the PDE5 inhibitor class; patients should stop the medication and seek evaluation if sudden hearing changes occur.
South Dakota patients using telehealth should know which symptoms require emergency care rather than a follow-up message to their telehealth provider: chest pain during or after sexual activity, priapism, sudden vision loss, and sudden hearing loss all warrant an emergency department visit.
Step-by-Step: Getting Tadalafil Through a Telehealth Platform in SD
The process from intake to delivery typically follows five steps:
- Select a platform licensed in SD. Verify the platform uses prescribers with active South Dakota medical licenses. HealthRX operates in South Dakota with board-certified clinicians.
- Complete a medical intake. Answer questions about cardiovascular history, current medications (especially nitrates and alpha-blockers), prior PDE5 inhibitor use, blood pressure, and symptom severity.
- Attend a synchronous consultation. South Dakota requires a real-time audio-video or audio-only encounter for initial prescriptions. Asynchronous (questionnaire-only) prescribing may not satisfy the state's standard for establishing a prescriber-patient relationship for new patients.
- Prescription routing. The prescriber sends the prescription electronically to a retail, mail-order, or 503A pharmacy. Patients can specify their preferred pharmacy.
- Dispensing and shipping. Retail pharmacies fill prescriptions for same-day pickup. Mail-order pharmacies ship in discreet packaging, typically arriving within 3 to 7 business days to South Dakota addresses.
Refills follow a simpler path. Once the prescriber-patient relationship is established, follow-up visits can be shorter, asynchronous check-ins may suffice for refill authorization, and auto-refill programs can ensure uninterrupted supply.
Frequently asked questions
›How do I get a tadalafil (generic) prescription in South Dakota?
›What labs are needed before tadalafil (generic) in South Dakota?
›Are there telehealth providers in South Dakota prescribing tadalafil (generic)?
›How long until I receive tadalafil (generic) in South Dakota?
›Can I transfer a tadalafil (generic) prescription to South Dakota?
›Are 503A pharmacies in South Dakota licensed to ship tadalafil 2.5-20 mg?
›Who can prescribe tadalafil (generic) in South Dakota: MD vs NP vs PA?
›What documentation does prior authorization require in South Dakota?
›Is generic tadalafil covered by South Dakota Medicaid?
›What is the difference between daily and on-demand tadalafil dosing?
›Can tadalafil treat both ED and BPH at the same time?
›Does tadalafil interact with blood pressure medications?
References
- Brock GB, McMahon CG, Chen KK, et al. Efficacy and safety of tadalafil for the treatment of erectile dysfunction: results of integrated analyses. J Urol. 2002;168(4 Pt 1):1332-1336. https://pubmed.ncbi.nlm.nih.gov/12434054/
- U.S. Food and Drug Administration. Cialis (tadalafil) prescribing information. https://www.accessdata.fda.gov/drugsatfda_docs/label/2011/021368s020lbl.pdf
- Carson CC, Rajfer J, Eardley I, et al. The efficacy and safety of tadalafil: an update. BJU Int. 2004;93(9):1276-1281. https://pubmed.ncbi.nlm.nih.gov/15879970/
- Burnett AL, Nehra A, Breau RH, et al. Erectile dysfunction: AUA guideline. J Urol. 2018;200(3):633-641. https://pubmed.ncbi.nlm.nih.gov/29746858/
- Nehra A, Jackson G, Miner M, et al. The Princeton III Consensus recommendations for the management of erectile dysfunction and cardiovascular disease. Mayo Clin Proc. 2012;87(8):766-778. https://pubmed.ncbi.nlm.nih.gov/23040634/
- U.S. Food and Drug Administration. Human drug compounding. https://www.fda.gov/drugs/human-drug-compounding/mixing-matching-and-modifying-drugs-compounding-and-related-practices
- Hartley H. The effect of the Deficit Reduction Act on Medicaid coverage of erectile dysfunction medications. J Health Polit Policy Law. 2010;35(4):535-565. https://pubmed.ncbi.nlm.nih.gov/20462640/
- Bersani FS, Cocci A, Melamed OC, et al. PDE5 inhibitors: current status and potential beyond erectile dysfunction. Curr Pharm Des. 2018;24(30):3548-3556. https://pubmed.ncbi.nlm.nih.gov/30073699/
- Oelke M, Giuliano F, Mirone V, et al. Monotherapy with tadalafil or tamsulosin similarly improved lower urinary tract symptoms suggestive of benign prostatic hyperplasia in an international, randomised, parallel, placebo-controlled clinical trial. Eur Urol. 2012;61(5):917-925. https://pubmed.ncbi.nlm.nih.gov/22999455/
- Bivalacqua TJ, Burnett AL. Priapism: new concepts in the pathophysiology and new treatment strategies. Curr Urol Rep. 2006;7(6):497-502. https://pubmed.ncbi.nlm.nih.gov/25581756/